Waters Corporation (WAT)
| Market Cap | 16.55B |
| Revenue (ttm) | 3.05B |
| Net Income (ttm) | 661.39M |
| Shares Out | 59.52M |
| EPS (ttm) | 11.09 |
| PE Ratio | 25.08 |
| Forward PE | 20.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 707,887 |
| Open | 281.01 |
| Previous Close | 277.72 |
| Day's Range | 276.00 - 281.12 |
| 52-Week Range | 276.00 - 423.56 |
| Beta | 1.05 |
| Analysts | Hold |
| Price Target | 374.07 (+34.56%) |
| Earnings Date | Aug 4, 2025 |
About X
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies soft... [Read more]
Financial Performance
In 2024, Waters's revenue was $2.96 billion, an increase of 0.07% compared to the previous year's $2.96 billion. Earnings were $637.83 million, a decrease of -0.69%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for WAT stock is "Hold." The 12-month stock price target is $374.07, which is an increase of 34.56% from the latest price.
News
Waters Corporation (WAT) Q2 2025 Earnings Call Transcript
Waters Corporation (NYSE:WAT) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Amol Chaubal - Senior VP & CFO Caspar Tudor - Head of Investor Relations Udit Batra - Pre...
Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results
Highlights Sales of $771 million exceeded guidance range; grew 9% as reported and 8% in constant currency GAAP EPS of $2.47 and non-GAAP EPS of $2.95, above mid-point of guidance range Instruments gre...
WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger o...
Top Stock Movers Now: Autodesk, Fortinet, Waters, and More
Major U.S. equities indexes were little changed at midday Monday, as investors weighed the possible impact of the latest tariff announcements from President Trump.
Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal
Waters (WAT) shares tumbled over 12% Monday morning after the analytics instruments maker said it plans to buy Becton Dickinson's (BDX) Biosciences & Diagnostic Solutions business in a Reverse Morris ...
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...
Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call
MILFORD, Mass. , July 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q2 2025 financial results conference call on Monday, August 4th, 2025 at 8:00 a.m.
Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity
News Summary Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security. Integration of Alliance™ iS HPLC System with Empower™ Soft...
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
News Summary Up to six-fold increase in performance robustness with StepWave™ XR Ion Guide versus Xevo TQ Absolute.1 Uses up to 50% less power and gas, and occupies up to 50% less bench space than oth...
Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality
News Summary Enables measurements up to 2 days earlier for antibody titers for both clone selection and bioprocess monitoring.1 Provides up to 7x improvements in sensitivity with novel high efficiency...
Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio
MILFORD, Mass. , May 21, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and c...
Waters Corporation to Present at the Jefferies Global Healthcare Conference
MILFORD, Mass. , May 16, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.
Waters Corp's India business boosted by rush for weight-loss drugs
U.S.-based Waters Corp , which makes medical equipment used in clinical testing, has seen a spurt in demand from drugmakers in India rushing to develop their versions of popular weight-loss drugs, a s...
Waters Corporation: Still A Hold After Q1 Earnings
Waters Corporation's stock remains a "Hold" due to high valuation multiples, despite a 35% increase in stock price and improved business performance. The company reported solid Q1 2025 results, with 3...
Waters Corporation (WAT) Q1 2025 Earnings Call Transcript
Waters Corporation (NYSE:WAT) Q1 2025 Earnings Conference Call May 6, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President and Chief Executive Officer...
Waters raises 2025 profit forecast on resilient demand for lab equipment
Waters raised its annual profit forecast on Tuesday, after reporting better-than-expected first quarter results due to higher demand for its medical instruments in Asia and the Americas.
Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance
News Summary Saves up to six months on compliant software validation in biopharmaceutical quality control.1 Reduces analysis time for biotherapeutic peptides and proteins by 20%.2 Enhances quality co...
Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results
Highlights Strong start to the year as first quarter 2025 sales of $662 million landed at the high-end of guidance range; grew 4% as reported and 7% in constant currency Results led by instrument grow...
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Initiated positions in Waters Corporation, Penumbra, McKesson, Masimo, and added to UnitedHealth Group due to strong market positions and growth potential. Waters Corporation's growth driven by biopha...
Waters Corporation Schedules First Quarter 2025 Earnings Conference Call
MILFORD, Mass. , April 8, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2025 financial results conference call on Tuesday, May 6th, 2025 at 8:00 a.m.
Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC
News Summary Boosts out-of-the-box sensitivity by up to 80 times with MaxPeakTM Premier columns.1 Delivers over threefold improvements in day-to-day reproducibility2 and decreases carryover by up to t...
Waters Corporation to Present at the Leerink Partners Global Healthcare Conference
MILFORD, Mass. , March 7, 2025 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra Ph.D.
Waters Corporation: Instrument Replacement Cycle Momentum, But Valuation Is A Concern
Waters Corp reported better-than-expected Q4'24 and FY'24 results, driven by strong performance in academia, government, and pharma segments, despite FX headwinds impacting gross margins. The company ...
Waters Corporation (WAT) Q4 2024 Earnings Call Transcript
Waters Corporation (NYSE:WAT) Q4 2024 Earnings Conference Call February 12, 2025 8:00 AM ET Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President & Chief Executive Off...
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2024 Financial Results
Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in constant ...